Patient Guide: A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 113 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05348785
Status: ACTIVE_NOT_RECRUITING
Condition: Parkinson Disease
Phase: PHASE2

Where You Can Participate

This study is available at 113 locations across the country.

Top locations include:
  • • Phoenix, Arizona
  • • Sun City, Arizona
  • • Los Angeles, California
  • • And 110 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80 - Join Clinical Trial NCTNCT05348785

How to Join This Clinical Trial - NCTNCT05348785

Learn how to participate in this PHASE2 trial studying an investigational therapy for Parkinson Disease. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Parkinson Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Parkinson Disease
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05348785 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 113 locations. Find a study site near you:

Clinical Research Site

Phoenix, Arizona 85054 - United States

Status: Contact for availability

Clinical Research Site

Sun City, Arizona 85351 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90033 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90048 - United States

Status: Contact for availability

Clinical Research Site

Pasadena, California 91105 - United States

Status: Contact for availability

Clinical Research Site

San Francisco, California 94143 - United States

Status: Contact for availability

Clinical Research Site

Aurora, Colorado 80045 - United States

Status: Contact for availability

Clinical Research Site

Englewood, Colorado 80113 - United States

Status: Contact for availability

Clinical Research Site

New Haven, Connecticut 06510 - United States

Status: Contact for availability

Clinical Research Site

Boca Raton, Florida 33486 - United States

Status: Contact for availability

And 103 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Parkinson Disease:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships